Work

From Mitochondrial Biology to Magic Bullet: Navitoclax Disarms BCL-2 in Chronic Lymphocytic Leukemia

Year: 2011

Type: article

Abstract: Article Tools UNDERSTANDING THE PATHWAY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2011.37.9339 Journal of Clinical Oncology - published online before print December 19, 2011 PMID: 22184389 From Mitochondrial Biology to Magic Bullet: Navitoclax Disarms BCL-2 in Chronic Lymphocytic Leukemia Loren D. WalenskyxLoren D. WalenskySearch for articles by this author Show More Dana-Farber Cancer Institute, Boston, MA https://doi.org/10.1200/JCO.2011.37.9339 First Page Full Text PDF Figures and Tables © 2011 by American Society of Clinical Oncology

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2011.37.9339

Author: Loren D. Walensky

Institution: Dana-Farber Cancer Institute

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute